MedPath

Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS

Phase 3
Conditions
Fast-track
Colon Cancer
Parenteral Nutrition
Interventions
Drug: Perioperative peripheral parenteral nutrition
Registration Number
NCT03606863
Lead Sponsor
Antonio Arroyo Sebastian
Brief Summary

Assess if administration of early nutrition support with Perioperative Peripheral Nutrition (PeriOliclimonel) N4-E) in patients undergoing colon cancer resection in an Enhanced Recovery After Surgery (ERAS) Protocol improve the results of morbi-mortality and hospitalization versus standard intravenous fluid therapy.

Detailed Description

The main objective is to determine if perioperative nutritional support with PeriOlimel N4-E, that reaches nutritional requirements of ERAS protocol for colorectal cancer surgery patients, can improve nutritional status so it decreases postoperative complications, hospital length of stay and costs, compared to conventional fluid therapy administration since patients receive oral nutrition at day 3-5.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • scheduled colorectal cancer surgery
  • ASA I-IV
Exclusion Criteria
  • Emergency surgery
  • Distant metastasis
  • Patient´s refusal to participate
  • Allergy or hypersensitivity to egg or soy protein
  • Advanced kidney or hepatic impairment
  • Severe bleeding disorders
  • Congenital abnormalities of amino acid metabolism
  • Hyperlipidemia and severe or difficult to control hyperglycemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Perioperative peripheral parenteral nutritionPerioperative peripheral parenteral nutritionPerioperative peripheral parenteral nutrition during 4 days
Primary Outcome Measures
NameTimeMethod
morbi-mortality30 days

Early Peripheral Parenteral Nutrition in patients undergoing colon cancer resection in an Enhanced Recovery After Surgery Protocol to improve the results of morbi-mortality and hospitalization versus standard intravenous fluid therapy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital General Universitario de Elche

🇪🇸

Elche, Alicante, Spain

© Copyright 2025. All Rights Reserved by MedPath